These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34115906)

  • 1. Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells.
    Furuta T; Oda T; Kiyoi K; Yusuke O; Kimura S; Kurimori K; Miyazaki Y; Yu Y; Furuya K; Akashi Y; Shimomura O; Tateno H
    Cancer Sci; 2021 Sep; 112(9):3722-3731. PubMed ID: 34115906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structural analysis of glycans expressed within tumors derived from pancreatic cancer patient-derived xenograft mouse models.
    Hasehira K; Furuta T; Shimomura O; Asada M; Oda T; Tateno H
    Biochem Biophys Res Commun; 2021 Jan; 534():310-316. PubMed ID: 33288196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma.
    Mawaribuchi S; Shimomura O; Oda T; Hiemori K; Shimizu K; Yamase K; Date M; Tateno H
    Glycobiology; 2023 May; 33(4):342-352. PubMed ID: 36728830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer:
    Kuroda Y; Oda T; Shimomura O; Louphrasitthiphol P; Mathis BJ; Tateno H; Hatano K
    Cancer Sci; 2023 Aug; 114(8):3364-3373. PubMed ID: 37203465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lectin drug conjugate therapy for colorectal cancer.
    Kitaguchi D; Oda T; Enomoto T; Ohara Y; Owada Y; Akashi Y; Furuta T; Yu Y; Kimura S; Kuroda Y; Kurimori K; Miyazaki Y; Furuya K; Shimomura O; Tateno H
    Cancer Sci; 2020 Dec; 111(12):4548-4557. PubMed ID: 33058342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC).
    Le K; Wang J; Zhang T; Guo Y; Chang H; Wang S; Zhu B
    Int J Med Sci; 2020; 17(4):422-427. PubMed ID: 32174772
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin.
    Kimura S; Oda T; Shimomura O; Enomoto T; Hashimoto S; Kuroda Y; Yu Y; Kurimori K; Furuta T; Miyazaki Y; Tateno H
    Eur Surg Res; 2020; 61(4-5):113-122. PubMed ID: 33503609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN.
    Tateno H; Matsushima A; Hiemori K; Onuma Y; Ito Y; Hasehira K; Nishimura K; Ohtaka M; Takayasu S; Nakanishi M; Ikehara Y; Nakanishi M; Ohnuma K; Chan T; Toyoda M; Akutsu H; Umezawa A; Asashima M; Hirabayashi J
    Stem Cells Transl Med; 2013 Apr; 2(4):265-73. PubMed ID: 23526252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.
    McDowell CT; Klamer Z; Hall J; West CA; Wisniewski L; Powers TW; Angel PM; Mehta AS; Lewin DN; Haab BB; Drake RR
    Mol Cell Proteomics; 2021; 20():100012. PubMed ID: 33581409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma.
    Jo JH; Kim SA; Lee JH; Park YR; Kim C; Park SB; Jung DE; Lee HS; Chung MJ; Song SY
    BMC Cancer; 2021 Nov; 21(1):1241. PubMed ID: 34794402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer.
    Gebauer F; Wicklein D; Horst J; Sundermann P; Maar H; Streichert T; Tachezy M; Izbicki JR; Bockhorn M; Schumacher U
    PLoS One; 2014; 9(11):e113023. PubMed ID: 25409014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma.
    Song W; Li Q; Wang L; Huang W; Wang L
    Sci Rep; 2015 Jun; 5():10081. PubMed ID: 26068418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic Adenovirus Expressing ST13 Increases Antitumor Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Against Pancreatic Ductal Adenocarcinoma.
    Zhang Y; Ye M; Huang F; Wang S; Wang H; Mou X; Wang Y
    Hum Gene Ther; 2020 Aug; 31(15-16):891-903. PubMed ID: 32475172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma.
    Raj D; Nikolaidi M; Garces I; Lorizio D; Castro NM; Caiafa SG; Moore K; Brown NF; Kocher HM; Duan X; Nelson BH; Lemoine NR; Marshall JF
    Clin Cancer Res; 2021 Mar; 27(5):1538-1552. PubMed ID: 33479048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A minimally invasive and simple screening test for detection of pancreatic ductal adenocarcinoma using biomarkers in duodenal juice.
    Mori Y; Ohtsuka T; Kono H; Nagayoshi Y; Ideno N; Aso T; Kozono S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2013 Mar; 42(2):187-92. PubMed ID: 23407480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycan expression profile of signet ring cell gastric cancer cells and potential applicability of rBC2LCN-targeted lectin drug conjugate therapy.
    Yang Y; Akashi Y; Shimomura O; Tateno H; Saito S; Hiemori K; Miyazaki Y; Furuta T; Kitaguchi D; Kuroda Y; Pakavarin L; Oda T
    Gastric Cancer; 2022 Sep; 25(5):896-905. PubMed ID: 35715659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PODXL1 promotes metastasis of the pancreatic ductal adenocarcinoma by activating the C5aR/C5a axis from the tumor microenvironment.
    Saito K; Iioka H; Maruyama S; Sumardika IW; Sakaguchi M; Kondo E
    Neoplasia; 2019 Dec; 21(12):1121-1132. PubMed ID: 31759250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.